Explore Bioxcel through 7 example sentences from English. Ideal for language learners, writers and word enthusiasts.
Bioxcel in a sentence
Using Bioxcel
- In the example corpus, bioxcel often appears in combinations such as: bioxcel therapeutics, of bioxcel.
Context around Bioxcel
- Average sentence length in these examples: 17.9 words
- Position in the sentence: 1 start, 5 middle, 1 end
- Sentence types: 7 statements, 0 questions, 0 exclamations
Corpus analysis for Bioxcel
- In this selection, "bioxcel" usually appears in the middle of the sentence. The average example has 17.9 words, and this corpus slice is mostly made up of statements.
- Around the word, stability, therapeutics and suffers stand out and add context to how "bioxcel" is used.
- Recognizable usage signals include shares of bioxcel therapeutics in and bioxcel therapeutics inc. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "bioxcel" sits close to words such as aakash, aanholt and aardwolf, which helps place it inside the broader word index.
Example types with bioxcel
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
In terms of both operations and fiscal stability, Bioxcel suffers from poor metrics. (13 words)
On Friday, January 20th, Frank Yocca sold 50,000 shares of BioXcel Therapeutics stock. (14 words)
Bank of America started coverage on shares of BioXcel Therapeutics in a research report on Wednesday, April 1st. (18 words)
BioXcel Therapeutics, Inc is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. (22 words)
Hennion & Walsh Asset Management Inc. grew its stake in shares of BioXcel Therapeutics by 14.5% during the fourth quarter. (20 words)
Raymond James & Associates bought a new stake in shares of BioXcel Therapeutics in the first quarter worth about $229,000. (20 words)
Example sentences (7)
BioXcel Therapeutics, Inc is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology.
Hennion & Walsh Asset Management Inc. grew its stake in shares of BioXcel Therapeutics by 14.5% during the fourth quarter.
In terms of both operations and fiscal stability, Bioxcel suffers from poor metrics.
On Friday, January 20th, Frank Yocca sold 50,000 shares of BioXcel Therapeutics stock.
Raymond James & Associates bought a new stake in shares of BioXcel Therapeutics in the first quarter worth about $229,000.
Bank of America started coverage on shares of BioXcel Therapeutics in a research report on Wednesday, April 1st.
Finally, SunTrust Banks started coverage on shares of BioXcel Therapeutics in a research note on Tuesday, November 12th.
Common combinations with bioxcel
These word pairs occur most frequently in English texts:
- bioxcel therapeutics 8×
- of bioxcel 5×